Xiaoli Ma, PC
Philadelphia, Pennsylvania, United States
Gastroenterologist in Philadelphia, Pennsylvania
121 N 9th St, Philadelphia, PA 19107
About Xiaoli Ma, PC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
4
Assembly Biosciences
3
Exact Sciences Corporation
1
Medical Procare PLLC
1
Clinical Trials at Xiaoli Ma, PC
During the past decade, Xiaoli Ma, PC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients
2010-09-01
2013-11-01
Completed
31
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B
2013-09-01
2022-08-31
Completed
426
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B
2013-09-01
2022-10-13
Completed
875
Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment
2014-07-24
2018-05-30
Completed
195
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
2014-12-09
2017-08-14
Terminated
241
A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection
2018-06-11
2019-07-05
Completed
73
A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)
2018-06-19
2019-06-21
Completed
25
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
2018-12-20
2021-04-26
Terminated
92
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Xiaoli Ma, PC
According to Clinical.Site data, the most researched conditions in "Xiaoli Ma, PC" are
"Chronic Hepatitis B" (6 trials), "HBV" (2 trials), "Chronic HBV Infection" (1 trials), "Chronic HIV Infection" (1 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "Xiaoli Ma, PC" in a lesser frequency.
Clinical Trials Intervention Types at Xiaoli Ma, PC
Most popular intervention types in "Xiaoli Ma, PC" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "ABI-H0731" (2 trials), "GS-4774" (2 trials), "Placebo Oral Tablet" (2 trials), "TAF" (2 trials) and "TAF Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Xiaoli Ma, PC
The vast majority of trials in "Xiaoli Ma, PC" are
9 trials for "All" genders.
Clinical Trials Status at Xiaoli Ma, PC
Currently, there are NaN active trials in "Xiaoli Ma, PC".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Xiaoli Ma, PC,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Xiaoli Ma, PC, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".